[Meta-analysis of extralevator abdominoperineal excision for rectal cancer]
- PMID: 28338169
[Meta-analysis of extralevator abdominoperineal excision for rectal cancer]
Abstract
Objective: To evaluate the efficacy of extralevator abdominoperineal excision (ELAPE) of rectal cancer.
Methods: PubMed, Cochrane Library and Embase database were searched for clinical studies comparing the ELAPE and abdominoperineal excision (APE) for rectal cancer between 2007 and 2016. Two reviewers independently screened the articles and extracted the data. The Newcastle-Ottawa Scale (NOS) was used to evaluate the quality of the observational studies and the score more than 5 points was the inclusion criteria. Cochrane Handbook for Systematic Reviews of Interventions v5.1.0 was used to evaluate the quality of the randomized controlled trials (RCT). Intra-operative perforation rate, circumferential resection margin (CRM) involvement, local recurrence rate, perineal wound complications were brought into meta-analysis by Review Manager 5.3 software.
Results: A total of 556 articles were retrieved and 12 articles were enrolled finally, including 11 observational studies and 1 RCT study. All the 12 articles were high quality (scores of all observational studies were more than 11 points, RCT study accorded with 6 criteria of the quality evaluation). A total of 3 788 patients were enrolled, including 2 141 cases of ELAPE and 1 647 cases of APE. Meta-analysis revealed that intra-operative perforation rate of ELAPE was lower than APE (RR=0.52, 95%CI:0.34-0.79, P=0.002). There were no significant differences between two groups in CRM involvement (RR=0.72, 95%CI:0.49-1.07, P=0.10), local recurrence rate (OR=0.55, 95%CI:0.24-1.29, P=0.17) and perineal wound complications (RR=0.94, 95%CI:0.58-1.53, P=0.800).
Conclusions: Compared with APE, ELAPE reduces the intra-operative perforation rate, and does not increase the perineal wound complications, but it has no advantages in decreasing the CRM involvement and local recurrence rate.
Similar articles
-
Extralevator versus standard abdominoperineal excision for rectal cancer.Tech Coloproctol. 2015 Mar;19(3):145-52. doi: 10.1007/s10151-014-1243-8. Epub 2014 Nov 11. Tech Coloproctol. 2015. PMID: 25384360
-
[Meta-analysis of extralevator abdominoperineal excision and conventional abdominoperineal excision for low rectal cancer].Zhonghua Wei Chang Wai Ke Za Zhi. 2013 Jul;16(7):622-7. Zhonghua Wei Chang Wai Ke Za Zhi. 2013. PMID: 23888442 Chinese.
-
Extralevator abdominoperineal excision for low rectal cancer: a systematic review and meta-analysis of the short-term outcome.Colorectal Dis. 2015 Jun;17(6):474-81. doi: 10.1111/codi.12921. Colorectal Dis. 2015. PMID: 25704132
-
Comparison of short- and long-term outcomes after extralevator abdominoperineal excision and standard abdominoperineal excision for rectal cancer: a systematic review and meta-analysis.Int J Colorectal Dis. 2014 Feb;29(2):183-91. doi: 10.1007/s00384-013-1793-7. Epub 2013 Nov 23. Int J Colorectal Dis. 2014. PMID: 24271080
-
Extralevator with vs nonextralevator abdominoperineal excision for rectal cancer: the RELAPe randomized controlled trial.Colorectal Dis. 2017 Feb;19(2):148-157. doi: 10.1111/codi.13436. Colorectal Dis. 2017. PMID: 27369739 Clinical Trial.
Cited by
-
Clinical Robotic Surgery Association (India Chapter) and Indian rectal cancer expert group's practical consensus statements for surgical management of localized and locally advanced rectal cancer.Front Oncol. 2022 Oct 4;12:1002530. doi: 10.3389/fonc.2022.1002530. eCollection 2022. Front Oncol. 2022. PMID: 36267970 Free PMC article.
-
The quality of lymph node harvests in extralevator abdominoperineal excisions.BMC Surg. 2020 Oct 16;20(1):241. doi: 10.1186/s12893-020-00898-2. BMC Surg. 2020. PMID: 33066759 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous